CD44 and neoplasm: Histology indicated elevated SA-β-gal positivity in tumor tissues of mice that experienced MIT treatment, but exposure to PDK4-IN resulted in a lower SA-β-gal positivity, suggesting that PDK4 likely contributes to cellular senescence in animals undergoing chemotherapy (Fig. 5d,e).